Unoprostone Isopropyl Patent Expiration
Unoprostone Isopropyl is Used for treating ocular hypertension. It was first introduced by Sucampo Pharma Americas Llc
Unoprostone Isopropyl Patents
Given below is the list of patents protecting Unoprostone Isopropyl, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Rescula | US6458836 | Treatment of ocular hypertension and glaucoma |
Jul 09, 2021
(Expired) | Sucampo Pharma Llc |
Rescula | US6770675 | Compositions and methods for reducing ocular hypertension |
Nov 24, 2018
(Expired) | Sucampo Pharma Llc |
Rescula | US5221763 | Prostaglandins of the F series |
Jul 15, 2012
(Expired) | Sucampo Pharma Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Unoprostone Isopropyl's patents.
Latest Legal Activities on Unoprostone Isopropyl's Patents
Given below is the list recent legal activities going on the following patents of Unoprostone Isopropyl.
Activity | Date | Patent Number |
---|---|---|
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 15 May, 2009 | US6458836 |
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 28 Mar, 2006 | US6458836 |
Recordation of Patent Grant Mailed Critical | 03 Aug, 2004 | US6770675 |
Patent Issue Date Used in PTA Calculation Critical | 03 Aug, 2004 | US6770675 |
Issue Notification Mailed Critical | 15 Jul, 2004 | US6770675 |
Receipt into Pubs | 02 Jul, 2004 | US6770675 |
Dispatch to FDC | 30 Jun, 2004 | US6770675 |
Application Is Considered Ready for Issue Critical | 30 Jun, 2004 | US6770675 |
Receipt into Pubs | 29 Jun, 2004 | US6770675 |
Receipt into Pubs | 26 May, 2004 | US6770675 |